The Pharmacy and Poisons Board (PPB) has issued an urgent recall of a faulty batch of ‘Sure’ lubricated condoms, citing significant health concerns.
In a statement on Wednesday, PPB CEO Dr. Fred Siyoi confirmed that the batch in question, Batch No. 2405055, failed a critical safety test, putting users at risk.
Manufactured by Indus Medicare Private Limited, the defective batch did not meet the required standards.
In the “freedom from holes (conductivity)” test, raising doubts about the product’s ability to provide reliable protection.
This alarming discovery prompted the PPB to take swift action to protect public health.
Dr. Siyoi urged all stakeholders, including pharmaceutical outlets, healthcare professionals, and the public, to act immediately.
“We advise all to quarantine the affected product and cease further distribution, sale, or use.
Return the product to the nearest healthcare facility or respective suppliers,” he stated emphatically.
The PPB also encouraged the public to be vigilant, urging them to report any suspected cases of substandard medicines or adverse drug reactions to their nearest healthcare facility or directly to the Board.
This proactive measure aims to ensure that any lingering risks are swiftly identified and addressed.
The recall highlights the importance of rigorous quality control in the production of essential health products.
Dr. Siyoi reassured the public of the Board’s commitment to safeguarding public health by ensuring only safe and effective products reach the market.
While the recall is a precautionary measure, it has stirred concern among users who rely on ‘Sure’ condoms for protection. The incident underscores the need for consumers to remain informed and vigilant when it comes to personal healthcare products.
The PPB’s response serves as a reminder of the shared responsibility between manufacturers, regulators, and the public to uphold safety standards. By addressing the issue promptly, the Board aims to mitigate risks and maintain trust in the healthcare system.
This latest development emphasizes the critical role of transparency and swift action in public health matters. For those affected, the recall is a call to prioritize safety and follow the Board’s guidelines to ensure their well-being.
